Product Description: Levofloxacin (hydrate) (Standard) is the analytical standard of Levofloxacin (hydrate). This product is intended for research and analytical applications. Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV. Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity[1][2][3][4].
Formula: C18H20FN3O4.1/2H2O
References: [1]Drlica K, et al. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997 Sep;61(3):377-92. /[2]Smee DF, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57(1-2):41-52./[3]JI B, et al. In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1995 Jun;39(6):1341-4./[4]Rand A, et al. Effect of levofloxacin on some body tissues in mice. Iraqi Journal of Veterinary Sciences, 2021.
CAS Number: 138199-71-0
Molecular Weight: 370.38
Research Area: Infection; Cancer
Target: Antibiotic;Bacterial;DNA/RNA Synthesis;Orthopoxvirus;Reference Standards;Topoisomerase
Deutsch
English
